| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 20 May 2025 | 6 May 2025 |
| Ganga Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 inter alia to consider and approve Audited Financial Results For The Half and Financial Year Ended on March 31 2025. Outcome of the Board Meeting held on May 20, 2025 (As Per BSE Announcement Dated on: 20/05/2025) | ||
| Board Meeting | 27 Mar 2025 | 27 Mar 2025 |
| Outcome of the Board Meeting held on Thursday, March 27, 2025 | ||
| Board Meeting | 8 Nov 2024 | 5 Nov 2024 |
| Ganga Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2024 inter alia to consider and approve The Un-Audited Financial Results Of The Company For The Half Year Ended On September 302024 Approved the Un-audited financial results of the Company for the half year ended on September 30, 2024. (As per BSE Announcement Dated on 08/11/2024) | ||
| Board Meeting | 7 Aug 2024 | 7 Aug 2024 |
| Outcome of Board Meeting held on Wednesday, August 07, 2024 | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.